|
MRK
|
Merck & Company Inc
|
IT
|
MI
|
|
MRK
|
Merck & Company, Inc.
|
US
|
NYSE
|
|
MRNS
|
Marinus Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MRVT
|
Miravant Medical Technologies Inc
|
US
|
US
|
|
MVP
|
Medical Developments International Ltd
|
AU
|
ASX
|
|
MXC
|
MGC Pharmaceuticals Ltd
|
AU
|
ASX
|
|
MYX
|
Mayne Pharma Group Ltd
|
AU
|
ASX
|
|
N1BI34
|
Neurocrine Biosciences Inc.
|
BR
|
SA
|
|
N1VS34
|
Novartis AG
|
BR
|
SA
|
|
N4P
|
N4 Pharma Plc
|
UK
|
LSE
|
|
NAVA
|
Navamedic ASA
|
NO
|
OL
|
|
NBRV
|
Nabriva Therapeutics AG
|
US
|
NASDAQ
|
|
NBY
|
NovaBay Pharmaceuticals, Inc.
|
US
|
AMEX
|
|
NEU
|
Neuren Pharmaceuticals Ltd
|
AU
|
ASX
|
|
NGM
|
NGM Biopharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
NKTR
|
Nektar Therapeutics
|
US
|
NASDAQ
|
|
NMRA
|
Neumora Therapeutics Inc. Common Stock
|
US
|
US
|
|
NMTR
|
9 Meters Biopharma, Inc.
|
US
|
NASDAQ
|
|
NOVN
|
Novan, Inc.
|
US
|
NASDAQ
|
|
NUTEX
|
Nutex Investments PLC
|
HU
|
BUD
|